UBS Preps Acqui Deal

21 Jun 2007

Harlan Sprague Dawley has tapped the loan market for financing to back its acquisition of SafePharm.

Harlan Sprague Dawley has tapped the loan market for financing to back its acquisition of SafePharm. UBS leads the loans, which consist of a six-year, $30 million super-priority revolver divided between U.S. dollars and euros, and a seven-year, $330 million first-lien term loan. Pricing is LIBOR plus 2 ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.